BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33736682)

  • 1. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
    Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
    Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.
    Aroner SA; Collins LC; Schnitt SJ; Connolly JL; Colditz GA; Tamimi RM
    Breast Cancer Res; 2010; 12(4):R61. PubMed ID: 20691043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
    Visscher DW; Frost MH; Hartmann LC; Frank RD; Vierkant RA; McCullough AE; Winham SJ; Vachon CM; Ghosh K; Brandt KR; Farrell AM; Tarabishy Y; Hieken TJ; Haddad TC; Kraft RA; Radisky DC; Degnim AC
    Cancer; 2016 Feb; 122(3):378-85. PubMed ID: 26512815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer.
    Rohan TE; Arthur R; Wang Y; Weinmann S; Ginsberg M; Loi S; Salgado R
    Breast Cancer Res; 2021 Jan; 23(1):15. PubMed ID: 33516237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.
    Posso M; Corominas JM; Serrano L; Román M; Torá-Rocamora I; Domingo L; Romero A; Quintana MJ; Vernet-Tomas M; Baré M; Vidal C; Sánchez M; Saladié F; Natal C; Ferrer J; Servitja S; Sala M; Castells X;
    Cancer Med; 2017 Jun; 6(6):1482-1489. PubMed ID: 28470951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
    Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
    Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.
    Abubakar M; Fan S; Bowles EA; Widemann L; Duggan MA; Pfeiffer RM; Falk RT; Lawrence S; Richert-Boe K; Glass AG; Kimes TM; Figueroa JD; Rohan TE; Gierach GL
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33981950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.
    Worsham MJ; Abrams J; Raju U; Kapke A; Lu M; Cheng J; Mott D; Wolman SR
    Breast J; 2007; 13(2):115-21. PubMed ID: 17319851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies.
    Aroner SA; Collins LC; Connolly JL; Colditz GA; Schnitt SJ; Rosner BA; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2013 May; 139(1):277-85. PubMed ID: 23609472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
    Kabat GC; Jones JG; Olson N; Negassa A; Duggan C; Ginsberg M; Kandel RA; Glass AG; Rohan TE
    Cancer Causes Control; 2010 Jun; 21(6):821-8. PubMed ID: 20084540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.
    Sherman ME; Vierkant RA; Winham SJ; Vachon CM; Carter JM; Pacheco-Spann L; Jensen MR; McCauley BM; Hoskin TL; Seymour L; Gehling D; Fischer J; Ghosh K; Radisky DC; Degnim AC
    JAMA Surg; 2024 Feb; 159(2):193-201. PubMed ID: 38091020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
    Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.
    Román M; Caicoya M; Espinàs J; Sala M; Torá-Rocamora I; Quinta MJ; Vernet M; Saladié F; Romero A; Sánchez M; Baré M; Vidal C; Servitja S; Natal C; Corominas J; Ferrer J; Rodríguez-Arana A; Castells X;
    Breast J; 2018 Jul; 24(4):509-518. PubMed ID: 29517151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for breast cancer from benign breast disease in a diverse population.
    Worsham MJ; Raju U; Lu M; Kapke A; Botttrell A; Cheng J; Shah V; Savera A; Wolman SR
    Breast Cancer Res Treat; 2009 Nov; 118(1):1-7. PubMed ID: 18836828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptors in non-malignant mammary tissue modifies the association between insulin-like growth factor 1 and breast cancer risk.
    Samoli E; Lagiou A; Zourna P; Barbouni A; Georgila C; Tsikkinis A; Vassilarou D; Minaki P; Sfikas C; Spanos E; Trichopoulos D; Lagiou P
    Ann Oncol; 2015 Apr; 26(4):793-797. PubMed ID: 25542925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic features of breast cancers in women with previous benign breast disease.
    Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
    Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group.
    McDivitt RW; Stevens JA; Lee NC; Wingo PA; Rubin GL; Gersell D
    Cancer; 1992 Mar; 69(6):1408-14. PubMed ID: 1540878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
    Sherman ME; Vierkant RA; Masters M; Radisky DC; Winham SJ; Degnim AC; Vachon CM; Patel AV; Teras LR
    Cancer Prev Res (Phila); 2023 Mar; 16(3):175-184. PubMed ID: 36596665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
    Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
    Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.